| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB2 LIFR ADRB2 OR2M2 OR1S1 FPR3 NTSR1 NPSR1 DNER OR2M5 OR2M3 PLXNB2 IL18R1 UNC5D EDNRA | 2.71e-05 | 1353 | 66 | 15 | GO:0004888 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 2.60e-05 | 109 | 66 | 5 | GO:1904427 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 3.44e-05 | 192 | 66 | 6 | GO:0034767 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 5.38e-05 | 417 | 66 | 8 | GO:0034765 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 6.97e-05 | 218 | 66 | 6 | GO:1903169 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 1.35e-04 | 154 | 66 | 5 | GO:0051928 | |
| GeneOntologyBiologicalProcess | positive regulation of signaling receptor activity | 1.59e-04 | 33 | 66 | 3 | GO:2000273 | |
| GeneOntologyBiologicalProcess | muscle cell development | 1.79e-04 | 259 | 66 | 6 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 2.07e-04 | 266 | 66 | 6 | GO:0043270 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 2.19e-04 | 802 | 66 | 10 | GO:0048812 | |
| GeneOntologyBiologicalProcess | respiratory gaseous exchange by respiratory system | 2.25e-04 | 93 | 66 | 4 | GO:0007585 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 2.38e-04 | 273 | 66 | 6 | GO:0034764 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 2.38e-04 | 174 | 66 | 5 | GO:1904064 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.52e-04 | 392 | 66 | 7 | GO:0070588 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.59e-04 | 819 | 66 | 10 | GO:0120039 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 2.65e-04 | 97 | 66 | 4 | GO:0032414 | |
| GeneOntologyBiologicalProcess | maintenance of location | 2.68e-04 | 396 | 66 | 7 | GO:0051235 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.78e-04 | 826 | 66 | 10 | GO:0048858 | |
| GeneOntologyBiologicalProcess | T-tubule organization | 3.58e-04 | 9 | 66 | 2 | GO:0033292 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 3.85e-04 | 107 | 66 | 4 | GO:0032411 | |
| GeneOntologyBiologicalProcess | tube development | EPHB2 GJB1 ADRB2 PNPLA6 MEGF8 DCHS1 RNF213 STK40 DYSF PLXNB2 DICER1 EDNRA FBXW7 | 4.32e-04 | 1402 | 66 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | cell junction assembly | 4.49e-04 | 569 | 66 | 8 | GO:0034329 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 4.88e-04 | 48 | 66 | 3 | GO:0051281 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 4.93e-04 | 577 | 66 | 8 | GO:0043269 | |
| Domain | FerA | 3.57e-05 | 3 | 65 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 3.57e-05 | 3 | 65 | 2 | IPR012560 | |
| Domain | FerA | 3.57e-05 | 3 | 65 | 2 | PF08165 | |
| Domain | DysFC | 7.12e-05 | 4 | 65 | 2 | SM00694 | |
| Domain | DysFN | 7.12e-05 | 4 | 65 | 2 | SM00693 | |
| Domain | Peroxin/Ferlin | 7.12e-05 | 4 | 65 | 2 | IPR006614 | |
| Domain | FerI | 1.18e-04 | 5 | 65 | 2 | SM01202 | |
| Domain | FerB | 1.18e-04 | 5 | 65 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 1.18e-04 | 5 | 65 | 2 | IPR012561 | |
| Domain | Ferlin_C | 1.18e-04 | 5 | 65 | 2 | PF16165 | |
| Domain | Ferlin_C | 1.18e-04 | 5 | 65 | 2 | IPR032362 | |
| Domain | FerIin_dom | 1.18e-04 | 5 | 65 | 2 | IPR012968 | |
| Domain | FerI | 1.18e-04 | 5 | 65 | 2 | PF08151 | |
| Domain | FerB | 1.18e-04 | 5 | 65 | 2 | PF08150 | |
| Domain | fn3 | 2.51e-04 | 162 | 65 | 5 | PF00041 | |
| Domain | - | 4.59e-04 | 663 | 65 | 9 | 2.60.40.10 | |
| Domain | FN3 | 4.61e-04 | 185 | 65 | 5 | SM00060 | |
| Domain | GPCR_Rhodpsn_7TM | 4.95e-04 | 670 | 65 | 9 | IPR017452 | |
| Domain | 7tm_1 | 5.33e-04 | 677 | 65 | 9 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 5.80e-04 | 685 | 65 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 6.18e-04 | 691 | 65 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 6.24e-04 | 692 | 65 | 9 | IPR000276 | |
| Domain | FN3 | 6.42e-04 | 199 | 65 | 5 | PS50853 | |
| Domain | Ig-like_fold | 7.20e-04 | 706 | 65 | 9 | IPR013783 | |
| Domain | FN3_dom | 8.01e-04 | 209 | 65 | 5 | IPR003961 | |
| Domain | VWD | 1.39e-03 | 16 | 65 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.39e-03 | 16 | 65 | 2 | IPR001846 | |
| Domain | VWFD | 1.39e-03 | 16 | 65 | 2 | PS51233 | |
| Domain | VWD | 1.39e-03 | 16 | 65 | 2 | PF00094 | |
| Domain | PSI | 5.53e-03 | 32 | 65 | 2 | PF01437 | |
| Domain | - | 5.53e-03 | 32 | 65 | 2 | 3.40.1110.10 | |
| Domain | Plexin_repeat | 5.53e-03 | 32 | 65 | 2 | IPR002165 | |
| Domain | - | 5.53e-03 | 32 | 65 | 2 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 6.59e-03 | 35 | 65 | 2 | IPR023299 | |
| Pubmed | High-throughput microarray detection of olfactory receptor gene expression in the mouse. | 2.61e-08 | 4 | 66 | 3 | 15377787 | |
| Pubmed | 3.12e-07 | 30 | 66 | 4 | 32562661 | ||
| Pubmed | Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. | 3.55e-06 | 2 | 66 | 2 | 11959863 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 34354129 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 31004665 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19228595 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 18495154 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYOF PNPLA6 MEGF8 NTSR1 PCYT2 STK40 HERC2 DYSF PLXNB2 CDC42BPB LYST | 6.87e-06 | 1105 | 66 | 11 | 35748872 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 9.80e-06 | 552 | 66 | 8 | 10737800 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 30026467 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 37434585 | ||
| Pubmed | The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers. | 1.06e-05 | 3 | 66 | 2 | 23859474 | |
| Pubmed | Secondary PDZ domain-binding site on class B plexins enhances the affinity for PDZ-RhoGEF. | 1.06e-05 | 3 | 66 | 2 | 26627240 | |
| Pubmed | Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. | 1.06e-05 | 3 | 66 | 2 | 24177035 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 17185750 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 24687993 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 12183458 | ||
| Pubmed | EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. | 3.53e-05 | 5 | 66 | 2 | 11983165 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.22e-05 | 202 | 66 | 5 | 33005030 | |
| Pubmed | PNPLA6 ANAPC1 OBSL1 RNF213 OAS3 TAF2 KDM1B ACY1 DICER1 UNC5D | 4.59e-05 | 1116 | 66 | 10 | 31753913 | |
| Pubmed | Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry. | 5.08e-05 | 106 | 66 | 4 | 38891874 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 5.16e-05 | 697 | 66 | 8 | 28298427 | |
| Pubmed | Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. | 5.29e-05 | 6 | 66 | 2 | 24011077 | |
| Pubmed | Digital quantification of human eye color highlights genetic association of three new loci. | 5.29e-05 | 6 | 66 | 2 | 20463881 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 6.72e-05 | 724 | 66 | 8 | 36232890 | |
| Pubmed | Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation. | 7.40e-05 | 7 | 66 | 2 | 29130937 | |
| Pubmed | Cloning of three mouse Unc5 genes and their expression patterns at mid-gestation. | 7.40e-05 | 7 | 66 | 2 | 12351186 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 18454193 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 LIFR MYOF COL7A1 MEGF8 DNER RNF213 NECTIN3 ATP9A PLXNB2 | 8.45e-05 | 1201 | 66 | 10 | 35696571 |
| Pubmed | MYOF PTPN13 PNPLA6 ANAPC1 ARHGEF12 TAF2 KDM1B HERC2 ATP9A CDC42BPB DICER1 | 1.10e-04 | 1497 | 66 | 11 | 31527615 | |
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 23457482 | ||
| Pubmed | 1.68e-04 | 430 | 66 | 6 | 32581705 | ||
| Pubmed | 1.87e-04 | 58 | 66 | 3 | 23284291 | ||
| Pubmed | Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. | 1.93e-04 | 11 | 66 | 2 | 15186747 | |
| Pubmed | Analysis of Netrin 1 receptors during inner ear development. | 1.93e-04 | 11 | 66 | 2 | 17616930 | |
| Pubmed | Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. | 2.31e-04 | 12 | 66 | 2 | 12123608 | |
| Pubmed | 2.73e-04 | 13 | 66 | 2 | 26531127 | ||
| Pubmed | 2.93e-04 | 167 | 66 | 4 | 22159717 | ||
| Pubmed | 3.67e-04 | 15 | 66 | 2 | 24469813 | ||
| Pubmed | 3.67e-04 | 15 | 66 | 2 | 19436707 | ||
| Pubmed | 3.81e-04 | 179 | 66 | 4 | 18577758 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 4.06e-04 | 182 | 66 | 4 | 31067453 | |
| Pubmed | 4.16e-04 | 76 | 66 | 3 | 27542412 | ||
| Pubmed | 4.18e-04 | 16 | 66 | 2 | 32994313 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 4.24e-04 | 719 | 66 | 7 | 35337019 | |
| Pubmed | 5.32e-04 | 18 | 66 | 2 | 22541070 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 6.62e-04 | 1016 | 66 | 8 | 19056867 | |
| Pubmed | 6.82e-04 | 209 | 66 | 4 | 36779422 | ||
| Pubmed | Analyses of associations with asthma in four asthma population samples from Canada and Australia. | 7.27e-04 | 92 | 66 | 3 | 19247692 | |
| Pubmed | 7.28e-04 | 21 | 66 | 2 | 37422473 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 7.57e-04 | 377 | 66 | 5 | 38117590 | |
| Pubmed | 7.99e-04 | 22 | 66 | 2 | 22726835 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 7.99e-04 | 22 | 66 | 2 | 26494785 | |
| Pubmed | 8.75e-04 | 23 | 66 | 2 | 31748650 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 8.77e-04 | 1061 | 66 | 8 | 33845483 | |
| Pubmed | 8.98e-04 | 225 | 66 | 4 | 12168954 | ||
| Pubmed | Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. | 9.53e-04 | 24 | 66 | 2 | 26633881 | |
| Pubmed | 9.81e-04 | 601 | 66 | 6 | 33658012 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.01e-03 | 232 | 66 | 4 | 25515538 | |
| Pubmed | A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. | 1.03e-03 | 25 | 66 | 2 | 12544508 | |
| Pubmed | 1.04e-03 | 104 | 66 | 3 | 9205841 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.04e-03 | 104 | 66 | 3 | 31240132 | |
| Pubmed | APC7 mediates ubiquitin signaling in constitutive heterochromatin in the developing mammalian brain. | 1.21e-03 | 27 | 66 | 2 | 34942119 | |
| Pubmed | 1.21e-03 | 27 | 66 | 2 | 34242585 | ||
| Pubmed | 1.30e-03 | 28 | 66 | 2 | 26884322 | ||
| Pubmed | Molecular and anatomical characterization of parabrachial neurons and their axonal projections. | 1.39e-03 | 29 | 66 | 2 | 36317965 | |
| Pubmed | 1.45e-03 | 117 | 66 | 3 | 17145500 | ||
| Pubmed | 1.47e-03 | 257 | 66 | 4 | 16335952 | ||
| Pubmed | 1.47e-03 | 438 | 66 | 5 | 32628020 | ||
| Pubmed | The transcription factor gene Nfib is essential for both lung maturation and brain development. | 1.49e-03 | 30 | 66 | 2 | 15632069 | |
| Pubmed | 1.59e-03 | 31 | 66 | 2 | 23895693 | ||
| Pubmed | 1.59e-03 | 31 | 66 | 2 | 36159747 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.67e-03 | 910 | 66 | 7 | 36736316 | |
| Pubmed | 1.70e-03 | 32 | 66 | 2 | 23817571 | ||
| Pubmed | An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells. | 1.70e-03 | 32 | 66 | 2 | 28388416 | |
| Pubmed | 1.80e-03 | 126 | 66 | 3 | 16284245 | ||
| Pubmed | Liver and brain differential expression of one-carbon metabolism genes during ontogenesis. | 1.80e-03 | 33 | 66 | 2 | 34702858 | |
| Pubmed | 1.80e-03 | 33 | 66 | 2 | 18199763 | ||
| Cytoband | 1p36.1-p35 | 7.28e-05 | 9 | 66 | 2 | 1p36.1-p35 | |
| Cytoband | 1q44 | 5.49e-04 | 110 | 66 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 8.52e-04 | 128 | 66 | 3 | chr1q44 | |
| Cytoband | 20q11.23 | 1.31e-03 | 37 | 66 | 2 | 20q11.23 | |
| Cytoband | 3p21.1 | 1.69e-03 | 42 | 66 | 2 | 3p21.1 | |
| GeneFamily | Ferlin family | 8.63e-05 | 6 | 44 | 2 | 828 | |
| GeneFamily | Fibronectin type III domain containing | 6.09e-04 | 160 | 44 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.23e-04 | 161 | 44 | 4 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.22e-03 | 193 | 44 | 4 | 594 | |
| GeneFamily | Olfactory receptors, family 2 | 2.61e-03 | 113 | 44 | 3 | 149 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | EPHB2 PIK3AP1 MYOF FPR3 RNF213 OAS3 KDM1B DYSF PLXNB2 TNS1 LYST DICER1 CD163 | 9.99e-07 | 1012 | 65 | 13 | M40868 |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_UP | 9.54e-06 | 197 | 65 | 6 | M3120 | |
| Coexpression | NRL_DN.V1_DN | 1.95e-05 | 132 | 65 | 5 | M2797 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 4.62e-05 | 456 | 61 | 8 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 4.84e-05 | 459 | 61 | 8 | GSM777037_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.13e-04 | 827 | 61 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | 1.52e-04 | 403 | 61 | 7 | GSM605853_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 1.66e-04 | 409 | 61 | 7 | GSM605840_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 1.69e-04 | 410 | 61 | 7 | GSM854297_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 1.74e-04 | 412 | 61 | 7 | GSM605843_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | 1.82e-04 | 415 | 61 | 7 | GSM854299_500 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.36e-07 | 194 | 66 | 6 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.36e-07 | 194 | 66 | 6 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.36e-07 | 194 | 66 | 6 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 4.63e-07 | 196 | 66 | 6 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 4.77e-07 | 197 | 66 | 6 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.21e-07 | 200 | 66 | 6 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 173 | 66 | 5 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-06 | 173 | 66 | 5 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 175 | 66 | 5 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 179 | 66 | 5 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 7.11e-06 | 180 | 66 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | facs-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 182 | 66 | 5 | 45faefd7cbeac84d2c58650530b902af6ce921f8 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.55e-06 | 187 | 66 | 5 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 191 | 66 | 5 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 191 | 66 | 5 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.72e-06 | 192 | 66 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.72e-06 | 192 | 66 | 5 | 7bcdbd97fa8c3bfccde426d44979601226913fc3 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.97e-06 | 193 | 66 | 5 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-05 | 194 | 66 | 5 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 1.02e-05 | 194 | 66 | 5 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.02e-05 | 194 | 66 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-05 | 195 | 66 | 5 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.05e-05 | 195 | 66 | 5 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.07e-05 | 196 | 66 | 5 | 34c1c74cad5e23196e86cfd6f19c836fe57b2264 | |
| ToppCell | (001)_CD16+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 1.07e-05 | 196 | 66 | 5 | 33843d550cbca03c044d593b1f6972e4d3871f7f | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-05 | 197 | 66 | 5 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 66 | 5 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-05 | 198 | 66 | 5 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 1.13e-05 | 198 | 66 | 5 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 198 | 66 | 5 | cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-05 | 198 | 66 | 5 | 3bc3dbd178043deadd7eef413b2761dc003abd6e | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 1.13e-05 | 198 | 66 | 5 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.13e-05 | 198 | 66 | 5 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e | |
| ToppCell | severe_influenza-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.13e-05 | 198 | 66 | 5 | 790ee20abc9666b8095675b0d445c0914ee70ea3 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.13e-05 | 198 | 66 | 5 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-05 | 198 | 66 | 5 | 8b5d30312bbcabc6911ff03e5028766d77203dff | |
| ToppCell | Healthy-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.13e-05 | 198 | 66 | 5 | 4fd27a9fb3758c94ed9f0a726296e92b0625da44 | |
| ToppCell | Control-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class | 1.13e-05 | 198 | 66 | 5 | ae0a51e63e2751a6d9dc0c8a3852680949173523 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 198 | 66 | 5 | 7d8fade2583c07a33dd83057cbce08e9fc77987a | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 198 | 66 | 5 | 165d60b111a17d517a420c434733eefb98da240d | |
| ToppCell | 10x5'-Lung|World / Manually curated celltypes from each tissue | 1.13e-05 | 198 | 66 | 5 | a5cbe60caadd5b975906ecbc4eaa9795e4ebf885 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.16e-05 | 199 | 66 | 5 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 199 | 66 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-05 | 199 | 66 | 5 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-05 | 199 | 66 | 5 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | mLN-Macrophage-Macrophage|mLN / Region, Cell class and subclass | 1.16e-05 | 199 | 66 | 5 | 6bbec8450afb30347b07da28401a698fc51a3c53 | |
| ToppCell | mLN-(6)_Macrophage-(60)_Macrophage|mLN / shred on region, Cell_type, and subtype | 1.16e-05 | 199 | 66 | 5 | 1ea28b832c6173b1b58da432aaf21e6cd291561e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-05 | 199 | 66 | 5 | 18b6087863fda22e3e2a2167e7daeb347df1d95b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-05 | 199 | 66 | 5 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-05 | 200 | 66 | 5 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-05 | 200 | 66 | 5 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.18e-05 | 200 | 66 | 5 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.18e-05 | 200 | 66 | 5 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | COVID_non-vent-Myeloid|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.18e-05 | 200 | 66 | 5 | a40768e8e58c86b8e20bc188b9274ebe412fc765 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-05 | 200 | 66 | 5 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | Control-Control-Myeloid-CD16+_Monocyte|Control / Disease, condition lineage and cell class | 1.18e-05 | 200 | 66 | 5 | 8dd124a5aca897652ea68efbfc5a167b4cf31aef | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.57e-05 | 140 | 66 | 4 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.56e-05 | 146 | 66 | 4 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.67e-05 | 152 | 66 | 4 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 156 | 66 | 4 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 156 | 66 | 4 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 8.69e-05 | 157 | 66 | 4 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.35e-05 | 160 | 66 | 4 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 165 | 66 | 4 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 165 | 66 | 4 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.05e-04 | 165 | 66 | 4 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 166 | 66 | 4 | 1f39c7507ac6881aa1a30f8be22f98a1837d926b | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 66 | 4 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 66 | 4 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 172 | 66 | 4 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 172 | 66 | 4 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 173 | 66 | 4 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.29e-04 | 174 | 66 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 1.29e-04 | 174 | 66 | 4 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 176 | 66 | 4 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.35e-04 | 176 | 66 | 4 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.35e-04 | 176 | 66 | 4 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 177 | 66 | 4 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.38e-04 | 177 | 66 | 4 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.41e-04 | 178 | 66 | 4 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 179 | 66 | 4 | f99500c4a590e5152ded5862690f7fa614d64a80 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 179 | 66 | 4 | 7d61466181ab73088de3ec8a129d7cfa8cac7ecc | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-04 | 179 | 66 | 4 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 179 | 66 | 4 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 179 | 66 | 4 | 6c98ce32cb55cf9cee557449e41b23bdb22f5efd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 180 | 66 | 4 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 180 | 66 | 4 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 180 | 66 | 4 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 180 | 66 | 4 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 181 | 66 | 4 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 181 | 66 | 4 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.54e-04 | 182 | 66 | 4 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac|bone_marrow / Manually curated celltypes from each tissue | 1.54e-04 | 182 | 66 | 4 | e1d6b5de5bd1d11e968da3a55e5326ef252f55ba | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 182 | 66 | 4 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 1.60e-04 | 184 | 66 | 4 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.63e-04 | 185 | 66 | 4 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 185 | 66 | 4 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 185 | 66 | 4 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | Control-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class | 1.67e-04 | 186 | 66 | 4 | 0bf16ac48931b62bb3c33d63ff4279654148e293 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 186 | 66 | 4 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 9.36e-05 | 7 | 63 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.25e-04 | 8 | 63 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.44e-04 | 11 | 63 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | corneal resistance factor | 4.01e-04 | 451 | 63 | 6 | EFO_0010067 | |
| Disease | cortical surface area measurement | MFAP2 NEO1 ZAN CALHM1 ARHGEF12 NECTIN3 DYSF PLXNB2 TNS1 NOSIP | 5.28e-04 | 1345 | 63 | 10 | EFO_0010736 |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.78e-04 | 80 | 63 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 1.15e-03 | 96 | 63 | 3 | C1319315 | |
| Disease | diet measurement, bilirubin measurement | 1.41e-03 | 26 | 63 | 2 | EFO_0004570, EFO_0008111 | |
| Disease | non-alcoholic fatty liver disease (is_marker_for) | 1.52e-03 | 27 | 63 | 2 | DOID:0080208 (is_marker_for) | |
| Disease | glycocholate measurement | 1.88e-03 | 30 | 63 | 2 | EFO_0010491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNCIREDVAAYITRR | 156 | Q8TD30 | |
| IETLCVIAVDRYFAI | 121 | P07550 | |
| ARIRRENIVVYDVCA | 11 | Q5VT40 | |
| LAREVAVRYLRCISQ | 171 | Q8IU99 | |
| RREVAKTVFCLVVIF | 301 | P25101 | |
| ILCGIIFVERRYTAV | 441 | Q9UPY3 | |
| IRCGAETTVYVIVRC | 186 | Q6ZUJ8 | |
| VIDRCNYVRVGTTRV | 521 | O14983 | |
| SRSEIYGLVQRCVII | 61 | Q9NZN5 | |
| YLVRDCGIRTRVVSE | 71 | Q86WS3 | |
| RVGLITRSERYVCAV | 211 | Q9Y314 | |
| ICERSRLVVLSIALY | 866 | Q9H1A4 | |
| VYVAAVRLERVVLTC | 906 | O75147 | |
| TQDSVIYLVCVARRL | 416 | Q96JQ0 | |
| SRLAYVSCVRQLEVV | 1201 | Q8IY17 | |
| YVCIIRAVLRVSSTQ | 231 | Q8NH92 | |
| VVCLVTVCVIYRVDL | 341 | Q13478 | |
| FDRVVIYTTCLRVVR | 136 | A8MXD5 | |
| GVRVLRAVVIAFVVC | 301 | P30989 | |
| APDLVCRVVRYLQVV | 116 | Q6W5P4 | |
| RTLPKSVVDVCRVVY | 1471 | O95714 | |
| VSVYLITIIALDRCI | 111 | P25089 | |
| IAVVVIAIVCNRRGF | 556 | P29323 | |
| RTLSVLACRYVSEVV | 271 | Q99447 | |
| RYSVSTRIVCVIEAA | 851 | O15031 | |
| VAIIIASYARVILAV | 211 | Q96R28 | |
| VAIIIASYARVILAV | 211 | Q8NG83 | |
| VAIIIASYARVILAV | 211 | A3KFT3 | |
| VIVVIFVTVLVRCRH | 826 | Q9HC56 | |
| VLVVRGVRDRLVITY | 2586 | Q7Z7M0 | |
| CRRVLVQVSYAIGVA | 311 | Q00266 | |
| TVIREAVEEIRCYVR | 116 | O75110 | |
| VAVKRLILCYEIQRT | 1346 | Q9Y5S2 | |
| RVVVLFERCVISCAL | 371 | Q86UA1 | |
| VRLCGLEYIRTVIYI | 26 | Q9Y5Q6 | |
| VRIRCVQEVERILYF | 341 | Q8NB78 | |
| VAAVRCVQYDGRRVV | 501 | Q969H0 | |
| CIILNVAEVVYLIIR | 201 | P08034 | |
| VAEVVYLIIRACARR | 206 | P08034 | |
| REVCRSFVKIIAEVL | 1986 | Q99698 | |
| CLRTVPELIRYVTIV | 556 | O75342 | |
| RERVTCTRLYAADIV | 26 | Q02388 | |
| RDVGVVCSRYTEIRL | 571 | Q86VB7 | |
| ILIVGICRISRIEYQ | 656 | Q8NFT8 | |
| QECLVRIYIVRAFGL | 1576 | O75923 | |
| LLRARAIETQCYVVA | 241 | Q86X76 | |
| VTRGRCRVYVIAEES | 916 | Q8NG08 | |
| LRRVYVINKEICVRT | 126 | P55001 | |
| VAVIVGVVTSILCYR | 846 | P42702 | |
| CEDVIYARVSVRTVL | 136 | Q12923 | |
| RTVLELVTQYRQLCI | 996 | Q9Y6K5 | |
| AVVAAVALVYVLLRR | 796 | Q9UGT4 | |
| ERETVVIFYDVVRVV | 171 | Q8N2I9 | |
| YRHTITVSCLRAIRV | 846 | Q6P1X5 | |
| TIVVVVIIAVFCTRR | 1116 | Q92859 | |
| YRVVADHIRTLSVCI | 321 | Q5JTZ9 | |
| CVSIQYLEAVRRLKV | 116 | Q03154 | |
| ASVEYLQEVARIRLC | 4221 | Q63HN8 | |
| TQVAAVCRRLDIYAR | 96 | Q5TG30 | |
| CELDLVYVTERIIAV | 11 | Q9HBL0 | |
| ATYVERAQILLERCI | 286 | Q8IYQ7 | |
| VAVAVLVIGVTLYRR | 391 | Q6UXZ4 | |
| VINILVIAYCLSRAR | 276 | Q9H598 | |
| LAITRVYCNRASIRI | 56 | Q6BDS2 | |
| RVVAVSSVRLCARYQ | 81 | Q96H79 | |
| VVVLLAVTRECIYRT | 2771 | Q9Y493 | |
| QECTVRIYIVRGLEL | 1551 | Q9NZM1 | |
| IVLVSVLAGIFCYRR | 416 | Q9NQS3 |